SynapCell
SynapCell is an innovative preclinical CRO specializing in CNS efficacy testing using robust, translational and predictive EEG biomarkers. With over 20 years of expertise, SynapCell is a trusted partner for biotech and pharmaceutical companies advancing treatments for neurological and psychiatric disorders. As psychedelic therapeutics emerge, SynapCell offers standardized pharmaco EEG and vigilance-sleep platforms enabling Sponsors to benchmark lead candidates against our library of current standards of care and accelerate decision making in CNS drug development.
